In accordance with the present invention there is provided a pharmaceutical combination
useful for the treatment of viral infections comprising a at least one antiviral
active compound of formula (1):
##STR1##
and at least one further therapeutic agent chosen from nucleoside analogues;
NNRTIs; and protease inhibitors.
